AbbVie Inc. (ABBV) vs PepsiCo, Inc. (PEP)
A side-by-side comparison of AbbVie Inc. and PepsiCo, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; PEP is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$261.70HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT
PEP
PepsiCo, Inc.
$136.34Consumer DefensiveDelayed quote: Sep 14, 2026, 4:00 PM EDT
Total return — ABBV vs PEP
growth of $100 · dividends reinvested · last 10yABBV +512.0% (+19.9%/yr)PEP +75.2% (+5.8%/yr)ABBV compounded faster over this window
ABBV PEP
ABBV vs PEP: by the numbers
- •ABBV is the larger company ($462.37B vs $186.24B market cap).
- •PEP trades at the lower trailing earnings multiple (17.87 vs 73.73 P/E), one valuation lens rather than an overall verdict.
- •PEP converts more revenue to profit (10.82% vs 9.81% net margin).
- •PEP grew revenue faster over the past five years (5.37% vs 3.69% CAGR).
- •PEP pays the higher dividend yield (4.26% vs 2.66%).
Metrics side by side
Valuation
| Metric | ABBV | PEP |
|---|---|---|
| P/E ratio | 73.73 | 17.87 |
| Forward P/E | 18.63 | 15.94 |
| P/S ratio | 7.18 | 1.92 |
| P/B ratio | N/A | 8.43 |
| EV / EBITDA | 19.65 | 12.16 |
| FCF yield | 3.92% | 4.98% |
Profitability
| Metric | ABBV | PEP |
|---|---|---|
| Gross margin | 71.48% | 53.96% |
| Operating margin | 29.32% | 14.96% |
| Net margin | 9.81% | 10.82% |
| ROE | N/A | 47.45% |
| ROIC | 13.46% | 13.22% |
Dividends
| Metric | ABBV | PEP |
|---|---|---|
| Dividend yield | 2.66% | 4.26% |
| Payout ratio | 192.43% | 76.08% |
Growth (annualized)
| Metric | ABBV | PEP |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 5.37% |
| EPS CAGR (5Y) | -2.79% | 3.25% |
| FCF CAGR (5Y) | 0.11% | 5.40% |
| Total return CAGR (5Y) | 23.70% | 0.61% |
Frequently asked
- Which has the lower trailing P/E, ABBV or PEP?
- PEP has the lower trailing P/E: ABBV trades at 73.73 and PEP at 17.87. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or PEP?
- Over the past five years, PEP grew revenue faster — ABBV at a 3.69% CAGR versus PEP at 5.37%.
- Does ABBV or PEP pay a bigger dividend?
- ABBV yields 2.66% and PEP yields 4.26% based on trailing dividends and the latest price.
- Is ABBV or PEP more profitable?
- PEP runs the higher net margin — ABBV at 9.81% versus PEP at 10.82%.
- How have ABBV and PEP total returns compared?
- Over the past 10 years, ABBV delivered 19.85% and PEP delivered 5.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioPepsiCo P/E ratioAbbVie dividend yieldPepsiCo dividend yieldAbbVie ROEPepsiCo ROEAbbVie operating marginPepsiCo operating marginAbbVie revenue growthPepsiCo revenue growthAbbVie free cash flowPepsiCo free cash flow
AbbVie & PepsiCo appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.